In addition, they more often had a history of coronary artery disease, but less often previous stroke, heart failure, or peripheral artery disease
It affects a significant majority of people starting GLP-1 treatment, with studies showing that 40 to 50 percent of patients experience nausea, particularly during dose escalation
Combining TB500 and BPC-157, this research-grade product is manufactured to high purity standards for reliable research applications
JAMA 329 , 13761385 (2023)
While its highly effective in managing diabetes, some individuals may experience hair loss as an unwanted consequence
This scenario was illustrated in our previous dynamic study on GCGR 15